Review

The gut microbiota-miRNA axis in multiple sclerosis: Mechanisms and therapeutic potentials.

Farzaneh Rafie Sedaghat A. Hasani V. Poortahmasebi S. Hosseini Hossein Samadi Kafil Mehdi Meskini Heydarlou Somayeh Ahmadi Elham Mehdizadehfar Yalda Sadeghpour Roqaiyeh Hasani Tohid Samadpour Zahmat-Dar

Aug 2026 · Folia Microbiologica (Prague) · 0 citations · 120 references

Medicine

TL;DR

A better understanding of the GM-miRNA axis may facilitate the development of novel biomarkers and personalized therapeutic strategies, ultimately shifting MS management from symptomatic treatment toward precision, disease-modifying interventions.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Aug 2026

The Emerging Role of Peripheral Anti-Inflammatory Agents in Modulating Neurodegenerative Pathology: A Cross-Domain Review

This review synthesizes recent advances in understanding how peripheral immunity and gut microbiota influence neurodegenerative processes, highlighting key signaling pathways and mechanisms and examines current therapeutic strategies.

Vishwadeep Singh, V. Saxena, Sanskriti Upadhyay · Journal of Human Nutrition a... · 0 citations

Review Sep 2026

Deconstructing the microbiota-gut-brain axis in multiple sclerosis: from a barrier-immune-metabolic framework to emerging therapeutics.

BACKGROUND Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system characterized by progressive neuroinflammation and demyelination. Increasing evidence suggests that the gut microbiota contributes to MS pathogenesis through bidirectional gut-brain interactions; however, the underlyin...

Jin-Xin Wang, Fang Zheng, Yu-Chen Zhang et al. · Multiple Sclerosis and Relat... · 0 citations

Review Open access Aug 2026

Immuno-Metabolic Interactions Along the Microbiota-Gut-Brain Axis in Ischemic Stroke: A Narrative Review.

BACKGROUND AND PURPOSE Ischemic stroke (IS) remains a leading global cause of mortality and disability. Although current reperfusion strategies have advanced, the complex pathological mechanisms underlying IS continue to significantly limit clinical prognosis. Recently, the pivotal role of the microbiota-gut-brain axis...

Zhengyuan Liu, Xin-Wei Zhao, Ze-Yu Yang et al. · Journal of Stroke & Cerebrov... · 0 citations

Review Open access Sep 2026

Gut microbiota–neuroimmune crosstalk in autoimmune encephalitis: mechanistic insights and therapeutic prospects

Autoimmune encephalitis (AE) comprises a heterogeneous group of inflammatory disorders of the central nervous system mediated by autoimmune responses, involving multiple pathological processes, including autoantibody production, aberrant immune-cell activation, and persistent neuroinflammation. In recent years, accumul...

Hai-Yang Zhang, Xue Zhou, Yu-Gang Ma et al. · Frontiers in Microbiology · 0 citations

Review Sep 2026

The Gut-Brain Axis: Exploring the Role of Gut Microbiota in Alzheimer's Disease Pathogenesis and Therapeutics.

The gut microbiota acts as an upstream regulator of AD pathology through interconnected molecular mechanisms, and microbiota-targeted interventions have the potential to modulate these pathways and improve cognitive outcomes, although results vary across studies.

Javeria Fatima, Y. Siddique · CNS and Neurological Disorde... · 0 citations

Review Open access Sep 2026

Gut-brain immune dysregulation in Parkinson’s disease: a hypothesis-forming narrative review of trained immunity

Parkinson’s disease (PD) is increasingly understood as a multisystem disorder in which gastrointestinal dysfunction, immune remodeling, protein aggregation, and central neurodegeneration interact across the disease course. Although gut microbiota alterations are repeatedly reported in PD, taxonomic differences alone do...

Ming X. Tang, Jing-Xian Li, Chuan-Zhang Zhang et al. · Frontiers in Aging Neuroscie... · 0 citations